Notable Labs, Ltd. (NTBL)
(Delayed Data from NSDQ)
$0.49 USD
+0.01 (1.77%)
Updated Aug 8, 2024 03:54 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Cash flow Statements
Fiscal Year End for Notable Labs, Ltd falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -11.26 | -32.30 | -29.92 | -24.23 | -19.46 |
Depreciation/Amortization & Depletion | 0.26 | 1.06 | 1.26 | 1.19 | 1.71 |
Net Change from Assets/Liabilities | -0.70 | -2.63 | 1.71 | -2.06 | 2.61 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -2.01 | 2.28 | 1.97 | 1.72 | 2.57 |
Net Cash From Operating Activities | -13.72 | -31.59 | -24.98 | -23.38 | -12.70 |
Property & Equipment | -0.07 | -0.81 | -1.47 | -0.05 | -0.07 |
Acquisition/ Disposition of Subsidiaries | 15.61 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 28.11 | -14.02 | 9.94 | -6.53 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 15.54 | 27.30 | -15.49 | 9.89 | -6.60 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 3.99 | 0.02 | 51.42 | 17.46 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | -0.06 | 0.00 | -0.10 | -0.39 | -0.76 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 3.90 | 0.00 | -2.20 | 0.00 | 0.00 |
Net Cash from Financing Activities | 7.82 | 0.02 | 49.11 | 17.07 | -0.76 |
Effect of Exchange Rate Changes | 0.60 | -0.05 | 0.02 | 0.18 | 0.14 |
Net Change In Cash & Equivalents | 10.24 | -4.32 | 8.65 | 3.76 | -19.91 |
Cash at Beginning of Period | 1.58 | 22.35 | 13.70 | 9.94 | 29.35 |
Cash at End of Period | 11.83 | 18.03 | 22.35 | 13.70 | 9.44 |
Diluted Net EPS | -3.41 | -14.69 | -15.73 | -19.23 | -18.88 |
Fiscal Year End for Notable Labs, Ltd falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -3.77 | -11.26 | -4.58 | -3.51 |
Depreciation/Amortization & Depletion | NA | 0.06 | 0.26 | 0.00 | 0.00 |
Net Change from Assets/Liabilities | NA | -0.09 | -0.70 | -3.42 | -0.81 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 0.23 | -2.01 | 0.36 | 0.28 |
Net Cash From Operating Activities | NA | -3.56 | -13.72 | -7.64 | -4.05 |
Property & Equipment | NA | -0.01 | -0.07 | 7.45 | 7.29 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 15.61 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 3.00 | 3.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -0.01 | 15.54 | 10.45 | 10.29 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 3.99 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | -0.02 | -0.06 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 3.90 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | -0.02 | 7.82 | 0.00 | 0.00 |
Effect of Exchange Rate Changes | NA | -0.07 | 0.60 | -0.07 | 0.00 |
Net Change In Cash & Equivalents | NA | -3.65 | 10.24 | 2.74 | 6.24 |
Cash at Beginning of Period | NA | 11.83 | 1.58 | 18.03 | 18.03 |
Cash at End of Period | NA | 8.17 | 11.83 | 20.77 | 24.26 |
Diluted Net EPS | NA | -0.42 | -1.53 | -0.48 | -0.35 |